PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
21.88%
Net income growth above 1.5x TSM's 5.64%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
3.69%
D&A growth well above TSM's 2.12%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-971.43%
Negative yoy deferred tax while TSM stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-1.43%
Negative yoy SBC while TSM is 0.02%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
61.66%
Less working capital growth vs. TSM's 386.27%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-89.07%
AR is negative yoy while TSM is 176.57%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-216.95%
Both reduce yoy inventory, with TSM at -213.35%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-6.15%
Both negative yoy AP, with TSM at -348.19%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
113.77%
Some yoy usage while TSM is negative at -32.78%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
840.00%
Well above TSM's 48.03%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
99.67%
Operating cash flow growth above 1.5x TSM's 17.97%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-23.53%
Both yoy lines negative, with TSM at -25.84%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
70.44%
Some acquisitions while TSM is negative at -167.56%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-29.66%
Both yoy lines negative, with TSM at -26.07%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
173.00%
Proceeds from sales/maturities above 1.5x TSM's 68.35%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
41.18%
Less 'other investing' outflow yoy vs. TSM's 168.57%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
64.24%
We have mild expansions while TSM is negative at -18.43%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-97.32%
Negative yoy issuance while TSM is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-41.69%
We cut yoy buybacks while TSM is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.